Default company panoramic image
Logo

Kither Biotech S.r.l

Kither Biotech is a pharma product company focused on the development of new drugs for the treatment of chronic inflammation and cancer.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Turin, Piedmont, Italy
  • Currency EUR
  • Founded November 2011
  • Employees 2

Company Summary

Kither Biotech is a pharmaceutical product company, focused on the development of new drugs targeting PI3K enzymes involved in inflammation and cancer. Kither is committed to develop new molecules blocking PI3K for the treatment of chronic obstructive pulmonary disease, psoriasis and breast cancer. With these drugs, Kither intends to explore options for commercial exploitation, possibly through licensing agreements with pharmaceutical companies.

Team

  • Default avatar
    Alberto Bardelli
    Founder
    Unconfirmed

    Prof. at the University of Torino, Researcher and
    co-founder of Horizon Discovery, a successful British biotech company

  • Default avatar
    Emilio Hirsch
    Founder
    Unconfirmed

    Prof. at the University of Torino, with high experience in studying the role of PI3K enzymes in chronic inflammation and cancer

  • Default avatar
    Marco Kevin Malisani
    Founder/CEO
    Unconfirmed

    Business executive with extensive experience in funding and managing start-up companies in Italy and Great Britain

  • Default avatar
    Gian Cesare Tron
    Founder
    Unconfirmed

    Prof. at the University of Piemonte Orientale, chemist with experience in multicomponent reactions drug synthesis